Kayra Innopharm Private Limited

Kayra Innopharm Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U52609DL2018PTC337261 Incorporated 07 August 2018 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma
Revenue · FY 2024
₹1.86 Cr
▲ 47% YoY
Net profit · FY 2024
₹13.37 Lakh
Net margin 7.2%
EBITDA · FY 2024
₹16.92 Lakh
EBITDA margin 9.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹6.07 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings

About Kayra Innopharm Private Limited

Data last updated:

Kayra Innopharm Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 August 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52609DL2018PTC337261. Its GSTIN is 07AAHCK2178B1ZQ (Delhi).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pragya Arora and Kushagra Arora.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 303 Shriram Bhawan B – 5 Ranjit Nagar Commercial Complex, New Delhi, Delhi, India – 110008.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.86 Cr, a growth of 47% compared to the previous year. For the same year it recorded a net profit of ₹13.37 Lakh (net margin 7.2%) and EBITDA of ₹16.92 Lakh (EBITDA margin 9.1%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years and 53% over five years.

As per MCA filings, the company has open charges of ₹6.07 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it.

Company details

CIN U52609DL2018PTC337261
Registration Number 337261
Incorporation Date 07 August 2018
ROC Delhi
Listing Status Unlisted
Company Status Active

Contact details

Kayra Innopharm Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Flat No 303 Shriram Bhawan B – 5 Ranjit Nagar Commercial Complex, New Delhi, Delhi, India – 110008
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Kayra Innopharm Private Limited, buy the company report.

Comprehensive company report
Kayra Innopharm Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Kayra Innopharm is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles45Wholesale and retail trade and repair of motor vehicles and motorcycles

To see the full business activity and turnover split of Kayra Innopharm Private Limited, buy the company report.

Financials of Kayra Innopharm Private Limited

FY 2025 filings available

Kayra Innopharm Private Limited reported revenue of ₹1.86 Cr (up 47% YoY) for FY 2024.

Revenue · FY 2024
₹1.86 Cr ▲ 47%
Net profit · FY 2024
₹13.37 Lakh margin 7.2%
EBITDA · FY 2024
₹16.92 Lakh margin 9.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 47%
3 years · compounded
▲ 40%
5 years · compounded
▲ 53%
EBITDA CAGR growth
1 year
▲ 234%
3 years · compounded
▲ 198%
5 years · compounded
▲ 400%

Revenue has grown at a compounded annual rate (CAGR) of 53% over five years, including 47% growth in the latest year. EBITDA rose 234% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹16.92 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹13.37 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin9.1%
Net Profit Margin7.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Kayra Innopharm Private Limited, buy the company report.

Board of directors of Kayra Innopharm Private Limited

Kayra Innopharm has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Pragya AroraDirector07 Aug 20188 Years 3 MonthsCurrent
Kushagra AroraDirector07 Aug 20188 Years 3 MonthsCurrent
Shiv AroraDirector01 Jul 20197 Years 4 MonthsCurrent

Charges & borrowings

Open charges
₹6.07 Lakh
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹0.06 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Feb 2024100907428Hdfc Bank Limited₹6.07 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Kayra Innopharm Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Kayra Innopharm has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAHCK2178B1ZQDelhiActive08 Dec 2018

To see the full GST registrations and return filing status of Kayra Innopharm Private Limited, buy the company report.

Recent activity

Kayra Innopharm Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Shiv Arora was appointed as Director on 01 Jul 2019.

AGM
Kayra Innopharm Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Kayra Innopharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 6.07 Lakh with Charge ID 100907428 was registered on 27 Feb 2024.
Appointed
Shiv Arora was appointed as Director.
Appointed
Kushagra Arora was appointed as Director.
Appointed
Pragya Arora was appointed as Director.
Incorporation
07 Aug 2018
Kayra Innopharm Private Limited was registered on 07 Aug 2018 with Roc Delhi & aged 8 years 3 months as per MCA records.

Frequently asked questions

Kayra Innopharm is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 August 2018 (8+ years old) and is registered under CIN U52609DL2018PTC337261.

Kayra Innopharm has 3 current directors:

The latest financial statements of Kayra Innopharm on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Kayra Innopharm is 07AAHCK2178B1ZQ, registered in Delhi.

The CIN (Corporate Identification Number) of Kayra Innopharm is U52609DL2018PTC337261. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Kayra Innopharm has 2 court cases on record: 2 filed against it.

Kayra Innopharm was incorporated on 07 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.

Shiv Arora was appointed as Director on 01 Jul 2019. Kushagra Arora was appointed as Director on 07 Aug 2018. Pragya Arora was appointed as Director on 07 Aug 2018.

The registered office of Kayra Innopharm is at Flat No 303 Shriram Bhawan B – 5 Ranjit Nagar Commercial Complex, New Delhi, Delhi, India – 110008.

Kayra Innopharm operates in the pharma industry, in the drug formulation and development segment.